We are live on ! Find out more
SCA

Stonebridge Capital Advisors Portfolio holdings

AUM $1.43B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$222M
AUM Growth
+$17.3M
Cap. Flow
+$6.69M
Cap. Flow %
3.02%
Top 10 Hldgs %
24.45%
Holding
157
New
13
Increased
80
Reduced
39
Closed
4

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$2.46M
2
AFL icon
Aflac
AFL
+$1.32M
3
CVX icon
Chevron
CVX
+$1.13M
4
KYE
Kayne Anderson Energy
KYE
+$934K
5
PM icon
Philip Morris
PM
+$312K

Sector Composition

Rank Sector Weight
1 Financials 14.24%
2 Industrials 12.98%
3 Technology 11.85%
4 Consumer Discretionary 11.43%
5 Consumer Staples 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
76
Target
TGT
$63.4B
$981K 0.44%
16,934
+5,920
+54% +$348K
SCHW
77
Charles Schwab
SCHW
$178B
$980K 0.44%
36,394
+1,400
+4% +$36.7K
C icon
78
Citigroup
C
$216B
$945K 0.43%
+20,055
New +$954K
SYY icon
79
Sysco
SYY
$38.6B
$900K 0.41%
24,042
+500
+2% +$18.4K
AKAM icon
80
Akamai
AKAM
$17.9B
$893K 0.4%
14,630
+180
+1% +$10K
AMLP icon
81
Alerian MLP ETF
AMLP
$12.8B
$886K 0.4%
9,324
+956
+11% +$87.1K
IVV icon
82
iShares Core S&P 500 ETF
IVV
$879B
$844K 0.38%
4,283
+929
+28% +$178K
GS.PRD icon
83
Goldman Sachs Group Inc Series D Preferred Stock
GS.PRD
$1.03B
$839K 0.38%
41,105
-3,938
-9% -$79.9K
LH icon
84
Labcorp
LH
$23.1B
$804K 0.36%
9,143
-553
-6% -$47.9K
DOC icon
85
Healthpeak Properties
DOC
$15.4B
$739K 0.33%
19,607
+439
+2% +$16.5K
MMP
86
DELISTED
Magellan Midstream Partners, L.P.
MMP
$725K 0.33%
8,630
+800
+10% +$62.7K
ACN icon
87
Accenture
ACN
$88.6B
$669K 0.3%
8,278
-400
-5% -$32.1K
MDT icon
88
Medtronic
MDT
$107B
$648K 0.29%
10,164
+5
+0% +$304
PM icon
89
Philip Morris
PM
$300B
$640K 0.29%
7,596
-3,625
-32% -$312K
TSM icon
90
TSMC
TSM
$2.09T
$617K 0.28%
28,857
+2,000
+7% +$41.2K
BMY icon
91
Bristol-Myers Squibb
BMY
$123B
$616K 0.28%
+12,694
New +$626K
BWLD
92
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$572K 0.26%
3,450
IWP icon
93
iShares Russell Mid-Cap Growth ETF
IWP
$20.1B
$570K 0.26%
12,722
+1,080
+9% +$46.4K
GIS icon
94
General Mills
GIS
$20.1B
$560K 0.25%
10,651
+2
+0% +$107
MSFT icon
95
Microsoft
MSFT
$2.99T
$547K 0.25%
13,112
+515
+4% +$20.8K
PAYX icon
96
Paychex
PAYX
$41B
$542K 0.24%
13,045
+322
+3% +$13.2K
BBBY
97
DELISTED
Bed Bath & Beyond Inc
BBBY
$521K 0.23%
9,075
+50
+0.6% +$3.12K
CSR
98
Centerspace
CSR
$939M
$490K 0.22%
5,320
-528
-9% -$46.8K
LNT icon
99
Alliant Energy
LNT
$19.1B
$478K 0.22%
15,720
+1,738
+12% +$50.3K
FLR icon
100
Fluor
FLR
$6.91B
$468K 0.21%
6,090
-200
-3% -$15.2K

Similar funds

Stonebridge Capital Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Stonebridge Capital Advisors held 157 positions worth $222M, up 8.5% from $204M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Stonebridge Capital Advisors deployed $6.69M of net new capital in Q2 2014, opening 13 new positions and adding to 80 existing holdings. Its largest new stake was Citigroup: 20,055 shares worth $945K.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Allergan Inc, an estimated $2.46M trimmed.

  • Stonebridge Capital Advisors's largest Q2 2014 buy was Citigroup: 20,055 shares worth $945K.
  • Stonebridge Capital Advisors added most to Meta Platforms (Facebook) in Q2 2014, an estimated $1.48M increase.
  • Stonebridge Capital Advisors's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $2.46M.
  • Stonebridge Capital Advisors fully exited Aflac in Q2 2014, selling an estimated $1.32M.
  • Stonebridge Capital Advisors's ten largest holdings make up 24% of its $222M portfolio in Q2 2014.
  • Stonebridge Capital Advisors opened 13 new positions and closed 4 in Q2 2014.
  • Stonebridge Capital Advisors's portfolio value rose 8.5% quarter-over-quarter to $222M.

Based on Stonebridge Capital Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.